Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Joshua Choi
Johns Hopkins University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
38
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
PD-L1 pfeRNAs as Blood-Based Predictors of Treatment Response of Unresectable Malignant Pleural Mesothelioma Patients Administered Durvalumab with Cisplatin and Pemetrexed as First-Line Therapy
Number of pages: 17
Posted: 20 Dec 2024
Andrei Gurau
,
Suguru Yamauchi
,
Katie Ecoff
,
Kristen P. Rodgers
,
James R. Eshleman
,
Charles Conover Talbot Jr.
,
Peng Huang
, Joshua Choi,
Patrick M. Forde
,
Valsamo Anagnostou
,
Malcolm Brock
and
Yuping Mei
Johns Hopkins University, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University - Department of Oncology, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University, Johns Hopkins University and Johns Hopkins University
Downloads
38
(954,843)
View PDF
Download
Abstract:
PD-L1, pfeRNA, MPM, Durvalumab, Pemetrexed, Cisplatin, non-invasive biomarker
Feedback